These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7044864)

  • 21. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hypertrophic obstructive cardiomyopathy using verapamil].
    Hopf R; Keller M; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1054-7. PubMed ID: 1029919
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beta adrenergic receptors in patients with untreated and verapamil-treated hypertrophic cardiomyopathy].
    Kölbel F; Krulík R; Slíva D; Hradec J; Aschermann M; Simper D; Schreiber V
    Sb Lek; 1988 Jul; 90(7):218-22. PubMed ID: 2851875
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ergometric test in sympatheticotonia after administration of propranolol, pindolol, verapamil and oxazepam].
    Tkaczewski W; Goch JH; Wichan P; Kowalski J
    Pol Tyg Lek; 1980 Jun; 35(23):867-9. PubMed ID: 6997845
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertrophic obstructive myocardiopathy (considerations on 2 cases)].
    Maiorescu M; Serafim N; Ciofu E; Stamate M; Cănănău S; Radu M
    Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(4):319-28. PubMed ID: 6820559
    [No Abstract]   [Full Text] [Related]  

  • 26. Obstructive hypertrophic cardiomyopathy with left-sided cardiac failure: improvement after verapamil treatment.
    Eldar M; Hod H; Battler A; Rotstein Z; Feldman S; Rabinowitz B; Neufeld HN
    Am J Cardiol; 1984 Feb; 53(4):644-5. PubMed ID: 6538062
    [No Abstract]   [Full Text] [Related]  

  • 27. Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy.
    Woodcock BG; Hopf R; Kaltenbach M
    J Cardiovasc Pharmacol; 1980; 2(1):17-23. PubMed ID: 6154201
    [No Abstract]   [Full Text] [Related]  

  • 28. Common with the uncommon--atrial septal defect with hypertrophic cardiomyopathy.
    Matta R; Nair SK; Balakrishnan KG
    Indian Heart J; 1995; 47(4):372-4. PubMed ID: 8557282
    [No Abstract]   [Full Text] [Related]  

  • 29. Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy.
    Wessel A; Seiffert P; Dettmann R; Heintzen PH
    Eur Heart J; 1987 Mar; 8(3):313-5. PubMed ID: 3582389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Verapamil in end-stage heart failure due to hypertrophic obstructive cardiopathy].
    Brener Y; Kauli N
    Harefuah; 1981 Apr; 100(8):369-72. PubMed ID: 7196863
    [No Abstract]   [Full Text] [Related]  

  • 31. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration.
    Rosing DR; Condit JR; Maron BJ; Kent KM; Leon MB; Bonow RO; Lipson LC; Epstein SE
    Am J Cardiol; 1981 Sep; 48(3):545-53. PubMed ID: 7196690
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term treatment of hypertrophic obstructive cardiomyopathy--usefulness of verapamil.
    Kober G; Schmidt-Moritz A; Hopf R; Kaltenbach M
    Eur Heart J; 1983 Nov; 4 Suppl F():165-74. PubMed ID: 6686532
    [No Abstract]   [Full Text] [Related]  

  • 33. [Possibilities of a differentiated approach to the treatment of patients with idiopathic hypertrophic subaortic stenosis].
    Fedorova IF
    Vestn Akad Med Nauk SSSR; 1984; (2):52-5. PubMed ID: 6538734
    [No Abstract]   [Full Text] [Related]  

  • 34. A reduction in verapamil concentrations with phenytoin.
    Woodcock BG; Kirsten R; Nelson K; Rietbrock S; Hopf R; Kaltenbach M
    N Engl J Med; 1991 Oct; 325(16):1179. PubMed ID: 1891033
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemodynamic effects of intravenous verapamil in patients with obstructive myocardiopathy].
    Picó-Aracil F; Ruipérez JA; García Alberola A; Molina E; Ruiz-Ros JA; Campos JV; García J; Jaén E
    Rev Esp Cardiol; 1988 Jan; 41(1):16-21. PubMed ID: 3353560
    [No Abstract]   [Full Text] [Related]  

  • 36. Calcium antagonists in cardiomyopathy.
    Richardson PJ
    Br J Clin Pract Suppl; 1988 Apr; 60():33-7. PubMed ID: 3151269
    [No Abstract]   [Full Text] [Related]  

  • 37. [Early surgical treatment of symptomatic hypertrophic obstructive myocardiopathy. Arguments against].
    Tascón JC; Albarrán A; Andreu J; Alonso M
    Rev Esp Cardiol; 1995 Apr; 48(4):229-34. PubMed ID: 7740143
    [No Abstract]   [Full Text] [Related]  

  • 38. Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.
    Perrot B; Danchin N; Terrier de la Chaise A
    Br Heart J; 1984 Mar; 51(3):352-4. PubMed ID: 6538092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic Japanese-type apical hypertrophic cardiomyopathy in a non-Asian patient: favorable response to treatment with verapamil.
    Zack PM; Blausey WL
    Am Heart J; 1994 Sep; 128(3):613-6. PubMed ID: 8074027
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypertrophic cardiomyopathy: place and limitations of medical therapy].
    Desnos M; Hagège A; Guérot C
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):573-5. PubMed ID: 7487302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.